Evidence map›Paper›PMID 36186820›Full record

ArticleFrontiers in medicine2022

Piloting a systems level intervention to improve cervical cancer screening, treatment and follow up in Kenya.

Natabhona M Mabachi, Catherine Wexler, Harshdeep Acharya, May Maloba, Kevin Oyowe, Kathy Goggin, Sarah Finocchario-Kessler

Abstract read
In one paragraph

Article in Frontiers in medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Natabhona M MabachiPractice-Based Research, Innovation, and Evaluation Division, American Academy of Family Physicians, Leawood, KS, United States.
Catherine WexlerDepartment of Family and Community Medicine, University of Kansas Medical Center, Kansas City, KS, United States.
Harshdeep AcharyaDepartment of Family and Community Medicine, University of Kansas Medical Center, Kansas City, KS, United States.
May MalobaGlobal Health Innovations, Nairobi, Kenya.
Kevin OyoweGlobal Health Innovations, Nairobi, Kenya.
Kathy GogginChildren's Mercy Research Institute, Kansas City, MO, United States.
Sarah Finocchario-KesslerDepartment of Family and Community Medicine, University of Kansas Medical Center, Kansas City, KS, United States.

Funding

Evaluating the HITSystem to Improve PMTCT Retention and Maternal Viral Suppression in KenyaR01MH121245 · NIMH · UNIVERSITY OF KANSAS MEDICAL CENTER · PI KESSLER, SARAH FINOCCHARIO · 2020 to 2024
$3.5M
NIMH NIH HHS R01 MH121245
6 · The paper itself

Abstract

Although preventable, Cervical Cancer (CC) is the leading cause of cancer deaths among women in Sub-Saharan Africa with the highest incidence in East Africa. Kenyan guidelines recommend an immediate screen and treat approach using either Pap smear or visual screening methods. However, system (e.g., inadequate infrastructure, weak treatment, referral and tracking systems) and patient (e.g., stigma, limited accessibility, finance) barriers to comprehensive country wide screening continue to exist creating gaps in the pathways of care. These gaps result in low rates of eligible women being screened for CC and a high loss to follow up rate for treatment. The long-term goal of 70% CC screening and treatment coverage can partly be achieved by leveraging electronic health (eHealth, defined here as systems using Internet, computer, or mobile applications to support the provision of health services) to support service efficiency and client retention. To help address system level barriers to CC screening treatment and follow up, our team developed an eHealth tool-the Cancer Tracking System (CATSystem), to support CC screening, treatment, and on-site and external referrals for reproductive age women in Kenya. Preliminary data showed a higher proportion of women enrolled in the CATSystem receiving clinically adequate (patients tested positive were treated or rescreened to confirm negative within 3 months) follow up after a positive/suspicious screening, compared to women in the retrospective arm.

Indexed as

cervical cancer screeningcervical cancer trackingcervical cancer treatmenteHealth (mobile Health)Kenyasystem—level

Identifiers

PMID36186820
PMCPMC9520305

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.